AI-driven literature review is revolutionizing pharmacovigilance by automating data extraction, improving signal detection, and enhancing drug safety through faster, accurate, and comprehensive scientific analysis.

Generative AI is revolutionizing aggregate reporting in pharma, streamlining data analysis, enhancing accuracy, and accelerating compliance to improve drug safety and regulatory decision-making.

Gen AI is transforming pharmacovigilance by automating case processing, improving accuracy, and enabling faster drug safety decisions—shaping the future of patient protection.